ADME screen
Judge Dismisses Lawsuit Accusing Illumina, Affymetrix of Fraud, Theft of Trade Secrets
The federal court order dismissed the case with prejudice, which prevents the plaintiffs from raising the case again.
The effort is already bearing fruit, as the team has been able to validate several variants known to be connected with adverse drug reactions.
Agilent, Partners Developing Toxicology Testing Models with $6M NIH Grant
NEW YORK (GenomeWeb News) – Agilent Technologies announced that it and a team of researchers from six organizations are developing models for toxicology testing with a $6 million grant from the National Institutes of Health.
RainDance Inks Deals with 454, Ambry Targeting ADME Applications
RainDance is partnering with Roche 454 and Ambry in two separate alliances aimed at developing ADME gene screening panels for use on next-generation sequencing instruments.
UCSF, Optivia Get $430K Grant for ADME Tool Development
The partners aim to develop a transporter-based assay system capable of predicting absorption, distribution, metabolism, and excretion of drug candidates.